Expression, characterization, and preliminary X-ray crystallographic analysis of recombinant murine Follistatin-like 1 expressed in Drosophila S2 cells

BioScience Trends

Volumn 7, Issue 2, 2013, Pages 93-100

  Li, Lian ^a   Li, Xinxin ^a   Liu, Xue ^a   Dong, Yingying ^a   Geng, Yan ^b   Liu, Xinqi ^a   Ning, Wen ^a  

^a NANKAI UNIVERSITY   (China)

^b JIANGNAN UNIVERSITY   (China)

Author keywords

Affinity chromatography; Biological activity; Crystallization; Drosophila S2 cells; Follistatin like 1 (FSTL1)

Indexed keywords

FOLLISTATIN RELATED PROTEIN; MUTANT PROTEIN; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; CRYSTALLIZATION; CULTURE MEDIUM; CYTOLOGY; DROSOPHILA MELANOGASTER; ISOLATION AND PURIFICATION; METABOLISM; MINK; MOUSE; PLASMID; X RAY CRYSTALLOGRAPHY;

ANIMALS; CELL LINE; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; CULTURE MEDIA, CONDITIONED; DROSOPHILA MELANOGASTER; FOLLISTATIN-RELATED PROTEINS; MICE; MINK; MUTANT PROTEINS; PLASMIDS; RECOMBINANT PROTEINS;

EID: 84880636213     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2013.v7.2.93     Document Type: Article

References (36)

1. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature. 1990; 346:281-284.
2. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H. Activin-binding protein from rat ovary is follistatin. Science. 1990; 247:836-838.
3. de Winter JP, ten Dijke P, de Vries CJ, van Achterberg TA, Sugino H, de Waele P, Huylebroeck D, Verschueren K, van den Eijnden-van Raaij AJ. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors. Mol Cell Endocrinol. 1996; 116:105-114.
4. Pearce JJ, Penny G, Rossant J. A mouse cerberus/Danrelated gene family. Dev Biol. 1999; 209:98-110.
5. Umezu T, Yamanouchi H, Iida Y, Miura M, Tomooka Y. Follistatin-like-1, a diffusible mesenchymal factor determines the fate of epithelium. Proc Natl Acad Sci U S A. 2010; 107:4601-4606.
6. Geng Y, Dong Y, Yu M, Zhang L, Yan X, Sun J, Qiao L, Geng H, Nakajima M, Furuichi T, Ikegawa S, Gao X, Chen YG, Jiang D, Ning W. Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development. Proc Natl Acad Sci U S A. 2011; 108:7058-7063.
7. Sylva M, Li VS, Buffing AA, van Es JH, van den Born M, van der Velden S, Gunst Q, Koolstra JH, Moorman AF, Clevers H, van den Hoff MJ. The BMP Antagonist Follistatin-Like 1 Is Required for Skeletal and Lung Organogenesis. PLoS One. 2011; 6:e22616.
8. Xu J, Qi X, Gong J, Yu M, Zhang F, Sha H, Gao X. Fstl1 antagonizes BMP signaling and regulates ureter development. PLoS One. 2012; 7:e32554.
9. Dal-Pra S, Furthauer M, Van-Celst J, Thisse B, Thisse C. Noggin1 and Follistatin-like2 function redundantly to Chordin to antagonize BMP activity. Dev Biol. 2006; 298:514-526.
10. Esterberg R, Delalande JM, Fritz A. Tailbud-derived Bmp4 drives proliferation and inhibits maturation of zebrafish chordamesoderm. Development. 2008; 135:3891-3901.
11. Murakami K, Tanaka M, Usui T, Kawabata D, Shiomi A, Iguchi-Hashimoto M, Shimizu M, Yukawa N, Yoshifuji H, Nojima T, Ohmura K, Fujii T, Umehara H, Mimori T. Follistatin-related protein/follistatin-like 1 evokes an innate immune response via CD14 and toll-like receptor 4. FEBS Lett. 2012; 586:319-324.
12. Tanaka M, Ozaki S, Osakada F, Mori K, Okubo M, Nakao K. Cloning of follistatin-related protein as a novel autoantigen in systemic rheumatic diseases. Int Immunol. 1998; 10:1305-1314.
13. Ehara Y, Sakurai D, Tsuchiya N, Nakano K, Tanaka Y, Yamaguchi A, Tokunaga K. Follistatin-related protein gene (FRP) is expressed in the synovial tissues of rheumatoid arthritis, but its polymorphisms are not associated with genetic susceptibility. Clin Exp Rheumatol. 2004; 22:707-712.
14. Miyamae T, Marinov AD, Sowders D, Wilson DC, Devlin J, Boudreau R, Robbins P, Hirsch R. Follistatinlike protein-1 is a novel proinflammatory molecule. J Immunol. 2006; 177:4758-4762.
15. Clutter SD, Wilson DC, Marinov AD, Hirsch R. Follistatin-like protein 1 promotes arthritis by upregulating IFN-gamma. J Immunol. 2009; 182:234-239.
16. Chaly Y, Marinov AD, Oxburgh L, Bushnell DS, Hirsch R. FSTL1 promotes arthritis in mice by enhancing inflammatory cytokine/chemokine expression. Arthritis Rheum. 2012; 64:1082-1088.
17. Mashimo J, Maniwa R, Sugino H, Nose K. Decrease in the expression of a novel TGF ß1-inducible and rasrecision gene, TSC-36, in human cancer cells. Cancer Lett. 1997; 113:213-219.
18. Johnston IM, Spence HJ, Winnie JN, McGarry L, Vass JK, Meagher L, Stapleton G, Ozanne BW. Regulation of a multigenic invasion programme by the transcription factor, AP-1: Re-expression of a down-regulated gene, TSC-36, inhibits invasion. Oncogene. 2000; 19:5348-5358.
19. Sumitomo K, Kurisaki A, Yamakawa N, Tsuchida K, Shimizu E, Sone S, Sugino H. Expression of a TGFbeta1 inducible gene, TSC-36, causes growth inhibition in human lung cancer cell lines. Cancer Lett. 2000; 155:37-46.
20. Oshima Y, Ouchi N, Sato K, Izumiya Y, Pimentel DR, Walsh K. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart. Circulation. 2008; 117:3099-3108.
21. Shimano M, Ouchi N, Nakamura K, van Wijk B, Ohashi K, Asaumi Y, Higuchi A, Pimentel DR, Sam F, Murohara T, van den Hoff MJ, Walsh K. Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload. Proc Natl Acad Sci U S A.2011; 108:E899-906.
22. Brekken RA, Sage EH. SPARC, a matricellular protein: At the crossroads of cell-matrix. Matrix Biol. 2000; 19:569-580
23. Hambrock HO, Kaufmann B, Muller S, Hanisch FG, Nose K, Paulsson M, Maurer P, Hartmann U. Structural characterization of TSC-36/Flik: Analysis of two charge isoforms. J Biol Chem. 2004; 279:11727-11735.
24. Zhou J, Liao M, Hatta T, Tanaka M, Xuan X, Fujisaki K. Identification of a follistatin-related protein from the tick Haemaphysalis longicornis and its effect on tick oviposition. Gene. 2006; 372:191-198.
25. Grabarek Z. Structural basis for diversity of the EF-hand calcium-binding proteins. J Mol Biol. 2006; 359:509-525.
26. Kawabata D, Tanaka M, Fujii T, Umehara H, Fujita Y, Yoshifuji H, Mimori T, Ozaki S. Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis. Arthritis Rheum. 2004; 50:660-668.
27. Liu S, Wang L, Wang W, Lin J, Han J, Sun H, Guo H, Sun R, Wu Q. TSC-36/FRP inhibits vascular smooth muscle cell proliferation and migration. Exp Mol Pathol. 2006; 80:132-140.
28. van den Berg G, Somi S, Buffing AA, Moorman AF, van den Hoff MJ. Patterns of expression of the Follistatin and Follistatin-like1 genes during chicken heart development: A potential role in valvulogenesis and late heart muscle cell formation. Anat Rec (Hoboken). 2007; 290:783-787.
29. Javerzat S, Franco M, Herbert J, Platonova N, Peille AL, Pantesco V, De Vos J, Assou S, Bicknell R, Bikfalvi A, Hagedorn M. Correlating global gene regulation to angiogenesis in the developing chick extra-embryonic vascular system. PLoS One. 2009; 4:e7856.
30. Lara-Pezzi E, Felkin LE, Birks EJ, Sarathchandra P, Panse KD, George R, Hall JL, Yacoub MH, Rosenthal N, Barton PJ. Expression of follistatin-related genes is altered in heart failure. Endocrinology. 2008; 149:5822-5827.
31. El-Armouche A, Ouchi N, Tanaka K, Doros G, Wittkopper K, Schulze T, Eschenhagen T, Walsh K, Sam F. Follistatin-like 1 in chronic systolic heart failure: A marker of left ventricular remodeling. Circ Heart Fail. 2011; 4:621-627.
32. Widera C, Giannitsis E, Kempf T, Korf-Klingebiel M, Fiedler B, Sharma S, Katus HA, Asaumi Y, Shimano M, Walsh K, Wollert KC. Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome. Clin Chem. 2012; 58:1233-1241.
33. Ning W, Li CJ, Kaminski N, et al. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A. 2004; 101:14895-14900.
34. Ouchi N, Asaumi Y, Ohashi K, Higuchi A, Sono-Romanelli S, Oshima Y, Walsh K. DIP2A functions as a FSTL1 receptor. J Biol Chem. 2010; 285:7127-7134.
35. Johansen H, van der Straten A, Sweet R, Otto E, Maroni G, Rosenberg M. Regulated expression at high copy number allows production of a growth-inhibitory oncogene product in Drosophila Schneider cells. Genes Dev. 1989; 3:882-889.
36. Kirkpatrick RB, Ganguly S, Angelichio M, Griego S, Shatzman A, Silverman C, Rosenberg M. Heavy chain dimers as well as complete antibodies are efficiently formed and secreted from Drosophila via a BiP-mediated pathway. J Biol Chem. 1995; 270:19800-19805.